AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)
Title:
AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)
Author:
Zarrinkar, Patrick P. Gunawardane, Ruwanthi N. Cramer, Merryl D. Gardner, Michael F. Brigham, Daniel Belli, Barbara Karaman, Mazen W. Pratz, Keith W. Pallares, Gabriel Chao, Qi Sprankle, Kelly G. Patel, Hitesh K. Levis, Mark Armstrong, Robert C. James, Joyce Bhagwat, Shripad S.